Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia.
Sandlund JT, Harrison PL, Rivera G, Behm FG, Head D, Boyett J, Rubnitz JE, Gajjar A, Raimondi S, Ribeiro R, Hudson M, Relling M, Evans W, Pui CH. Sandlund JT, et al. Among authors: gajjar a. Blood. 2002 Jul 1;100(1):43-7. doi: 10.1182/blood.v100.1.43. Blood. 2002. PMID: 12070006 Free article.
Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy.
DeWire M, Green DM, Sklar CA, Merchant TE, Wallace D, Lin T, Vern-Gross T, Kun LE, Krasin MJ, Boyett JM, Wright KD, Wetmore C, Broniscer A, Gajjar A. DeWire M, et al. Among authors: gajjar a. Pediatr Blood Cancer. 2015 Feb;62(2):329-334. doi: 10.1002/pbc.25274. Epub 2014 Oct 18. Pediatr Blood Cancer. 2015. PMID: 25327609 Free PMC article.
A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.
Esbenshade AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P, Friedman HS, Gajjar A, Moghrabi A. Esbenshade AJ, et al. Among authors: gajjar a. Pediatr Blood Cancer. 2017 Jun;64(6):10.1002/pbc.26373. doi: 10.1002/pbc.26373. Epub 2016 Dec 21. Pediatr Blood Cancer. 2017. PMID: 28000417 Free PMC article. Clinical Trial.
Low-grade astrocytoma with neuraxis dissemination at diagnosis.
Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, Walter AW, Kuttesch JF, Muhlbauer M, Kun LE. Gajjar A, et al. J Neurosurg. 1995 Jul;83(1):67-71. doi: 10.3171/jns.1995.83.1.0067. J Neurosurg. 1995. PMID: 7782852
Response of pediatric low grade gliomas to chemotherapy.
Gajjar A, Heideman RL, Kovnar EH, Langston JA, Sanford RA, Douglass EC, Jenkins JJ, Horowitz ME, Kun LE. Gajjar A, et al. Pediatr Neurosurg. 1993 May-Jun;19(3):113-8; discussion 119-20. doi: 10.1159/000120714. Pediatr Neurosurg. 1993. PMID: 8499323 Review.
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S. Kun LE, et al. Among authors: gajjar a. Hum Gene Ther. 1995 Sep;6(9):1231-55. doi: 10.1089/hum.1995.6.9-1231. Hum Gene Ther. 1995. PMID: 8527482
570 results